Clinical Trials
24 trialsNCT00004863 2018-09-10
Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
Montefiore Medical Center
Phase 1 Completed
NCT00003899 2016-10-04
Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
Fred Hutchinson Cancer Center
Phase 1 Completed
NCT00005078 2015-06-08
Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
City of Hope Medical Center
Phase 1 Completed
NCT00009802 2013-12-19
Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors
University of Pittsburgh
Phase 1 Completed
NCT00009828 2013-12-19
Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors
University of Pittsburgh
Phase 1 Withdrawn
NCT00002939 2013-09-05
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer
University of Chicago
Phase 1 Completed
NCT00016874 2013-07-18
3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003555 2013-06-26
Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003004 2013-06-24
Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00003242 2013-06-24
Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00003742 2013-06-21
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00030368 2013-06-04
Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00002587 2013-06-03
Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00054548 2013-05-16
Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004173 2013-05-15
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00009932 2013-05-15
Combination Chemotherapy in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00287937 2013-02-07
Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00087217 2013-01-25
17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor
National Cancer Institute (NCI)
Phase 1 Completed
NCT00042809 2013-01-24
Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00028587 2013-01-16
PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00095914 2012-03-15
Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00005819 2010-06-11
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00006018 2010-06-11
Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00006257 2010-01-13
SU5416 and Paclitaxel in Treating Patients With Advanced Cancer
City of Hope Medical Center
Phase 1 Completed